ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,170Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 12

$495K Total Retail Price of All Prescriptions

Rank: 5 out of 12

390 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

28% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 7,695 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 679 255 S3 1 2
LISINOPRIL 560 399 2 3
FUROSEMIDE 559 406 3 4
POTASSIUM CHLORIDE 377 280 4 6
AMLODIPINE BESYLATE 377 215 4 5
SIMVASTATIN 355 264 6 7
METFORMIN HCL 307 188 7 15
METOPROLOL SUCCINATE 278 206 8 18
HYDROCHLOROTHIAZIDE 264 161 9 17
OMEPRAZOLE 234 185 10 8
LEVOTHYROXINE SODIUM 230 169 11 1
METOPROLOL TARTRATE 216 172 12 11
CARISOPRODOL 214 34 R 13 39
WARFARIN SODIUM 197 159 14 14
NEXIUM 197 106 14 22
GABAPENTIN 190 110 16 9
CARVEDILOL 177 150 17 28
ATORVASTATIN CALCIUM 157 101 18 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 100 19 42
CLONIDINE HCL 131 70 20 36
ATENOLOL 126 97 21 19
ZOLPIDEM TARTRATE 126 73 21 25
CYCLOBENZAPRINE HCL 120 29 R 23 61
LOSARTAN POTASSIUM 116 102 24 29
ALLOPURINOL 113 93 25 30
TAMSULOSIN HCL 110 82 26 31
AZITHROMYCIN 107 68 27 48
MELOXICAM 98 60 28 24
GLIPIZIDE 95 52 29 40
TRAMADOL HCL 93 47 30 20
LOVASTATIN 93 56 30 93
VERAPAMIL ER 87 45 32 58
PAROXETINE HCL 85 72 33 74
DICLOFENAC SODIUM 81 38 34 100
AMITRIPTYLINE HCL 80 44 R 35 57
LOSARTAN-HYDROCHLOROTHIAZIDE 78 54 36 49
ALENDRONATE SODIUM 77 53 37 23
ISOSORBIDE MONONITRATE ER 72 47 38 44
DIGOXIN 71 71 39 63
PROAIR HFA 70 18 40 82
CYMBALTA 70 46 40 37
CITALOPRAM HBR 69 36 42 12
TERAZOSIN HCL 69 55 42 81
RANITIDINE HCL 69 56 42 72
VENTOLIN HFA 67 41 45 80
GLIPIZIDE ER 64 54 46 66
CLOPIDOGREL 61 47 47 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 34 48 45
PEN NEEDLE 59 36 49 113
CRESTOR 54 54 50 61
LEVEMIR FLEXPEN 54 32 50 123
PLAVIX 54 41 50 34
ESCITALOPRAM OXALATE 54 37 50 35
TRIAMTERENE-HCTZ 53 32 54 40
JANUVIA 52 38 55 68
PREDNISONE 52 30 55 86
FLUOXETINE HCL 50 32 57 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.